User profiles for M. Desrosiers

Martin Desrosiers

Verified email at probionase.com
Cited by 13809

International consensus statement on allergy and rhinology: rhinosinusitis

…, NA Cohen, J DelGaudio, M Desrosiers… - International forum of …, 2016 - Wiley Online Library
Contributing Authors Isam Alobid, MD, PhD 1 , Nithin D. Adappa, MD 2 , Henry P. Barham,
MD 3 , Thiago Bezerra, MD 4 , Nadieska Caballero, MD 5 , Eugene G. Chang, MD 6 , Gaurav …

International consensus statement on allergy and rhinology: rhinosinusitis 2021

…, DB Conley, J DelGaudio, M Desrosiers… - International forum of …, 2021 - Wiley Online Library
I. Executive Summary Background The 5 years since the publication of the first International
Consensus Statement on Allergy and Rhinology: Rhinosinusitis (ICAR‐RS) has witnessed …

[HTML][HTML] A review of what is an emerging contaminant

S Sauvé, M Desrosiers - Chemistry Central Journal, 2014 - Springer
A review is presented of how one defines emerging contaminants and what can be included
in that group of contaminants which is preferably termed “contaminants of emerging concern…

[HTML][HTML] The challenge of mapping the human connectome based on diffusion tractography

…, A Boré, B Pinsard, C Bedetti, M Desrosiers… - Nature …, 2017 - nature.com
Tractography based on non-invasive diffusion imaging is central to the study of human brain
connectivity. To date, the approach has not been systematically validated in ground truth …

Efficacy and safety of dupilumab in patients with severe chronic rhinosinusitis with nasal polyps (LIBERTY NP SINUS-24 and LIBERTY NP SINUS-52): results from two …

C Bachert, JK Han, M Desrosiers, PW Hellings, N Amin… - The Lancet, 2019 - thelancet.com
Background Patients with chronic rhinosinusitis with nasal polyps (CRSwNP) generally
have a high symptom burden and poor health-related quality of life, often requiring recurring …

Mepolizumab for chronic rhinosinusitis with nasal polyps (SYNAPSE): a randomised, double-blind, placebo-controlled, phase 3 trial

…, W Fokkens, M Desrosiers, M Wagenmann… - The Lancet …, 2021 - thelancet.com
Background Chronic rhinosinusitis with nasal polyps affects approximately 2–4% of the
general population, and long-term use of systemic corticosteroids is associated with adverse …

Distinct immunopathologic characteristics of various types of chronic rhinosinusitis in adult Chinese

…, XJ You, YH Cui, DY Wang, M Desrosiers… - Journal of allergy and …, 2009 - Elsevier
BACKGROUND: Chronic rhinosinusitis (CRS) with nasal polyps (CRSwNP) and without
nasal polyps (CRSsNP) is reported to be different in inflammatory patterns of the sinonasal …

Efficacy and safety of benralizumab in chronic rhinosinusitis with nasal polyps: a randomized, placebo-controlled trial

C Bachert, JK Han, MY Desrosiers, P Gevaert… - Journal of Allergy and …, 2022 - Elsevier
… There were also fewer patients with a body mass index (BMI) of >30 kg/m 2 in the
benralizumab group compared with the placebo group. In the overall population, female …

Alum interaction with dendritic cell membrane lipids is essential for its adjuvanticity

TL Flach, G Ng, A Hari, MD Desrosiers, P Zhang… - Nature medicine, 2011 - nature.com
As an approved vaccine adjuvant for use in humans, alum has vast health implications, but,
as it is a crystal, questions remain regarding its mechanism. Furthermore, little is known …

Tooth loss, dementia and neuropathology in the Nun study

PS Stein, M Desrosiers, SJ Donegan, JF Yepes… - The Journal of the …, 2007 - Elsevier
Background Numerous studies have linked dementia to the subsequent deterioration of oral
health. Few investigators, however, have examined oral disease as a potential risk factor in …